What is the usual Absorica LD (isotretinoin) dosing?
Absorica LD (extended-release isotretinoin) is typically dosed based on body weight. Prescribing information generally targets a daily dose in the range of about 0.5 mg/kg/day to 1 mg/kg/day, with the exact starting dose and schedule set by the clinician and adjusted for tolerability.
For many patients, dosing is commonly started at the lower end and then adjusted based on side effects and response.
How is the daily dose calculated (mg/kg/day) and converted to capsules?
Clinicians usually calculate the target mg/kg/day dose from the patient’s weight (kg) and then choose the closest appropriate daily capsule strength regimen.
Because Absorica LD is an extended-release formulation, the dose is taken as prescribed as a once-daily regimen (not split across multiple doses unless specifically instructed by the prescriber).
How should Absorica LD be taken (timing with food)?
Absorica LD should be taken with food as directed by the label/prescriber, since food can affect isotretinoin absorption. The exact instructions can vary by product labeling and clinical practice, so the directions on the bottle and your dermatologist’s instructions should control.
What happens if I miss a dose?
If you miss a dose, you generally should not double up. Instead, take the next dose at the usual time. If you’re unsure, check your medication guide or ask your prescriber/pharmacist for the specific instruction that applies to your regimen.
How often are doses adjusted during treatment?
Dose adjustments are common during isotretinoin therapy based on side effects (like dryness, lab changes, or intolerance) and clinical response. This can mean reducing the dose or maintaining it if side effects are manageable, with follow-up visits and lab monitoring driving changes.
What if the patient has liver issues or abnormal labs?
Isotretinoin dosing and continuation often depend on lab results (commonly liver enzymes and lipids). Clinicians may reduce the dose, pause treatment, or discontinue based on how labs change and how severe side effects are.
Key safety point for dosing: pregnancy prevention requirements
Absorica LD (isotretinoin) carries a high risk of severe birth defects and is restricted under iPLEDGE-type pregnancy prevention requirements in the U.S. The dosing plan must be aligned with these requirements, and pregnancy testing and contraception rules must be followed exactly.
Sources
No sources were provided in your prompt, and I can’t verify exact Absorica LD capsule-by-capsule dosing instructions without the prescribing label or a reference link. If you share the patient’s weight and the capsule strengths you have available (and whether you’re using U.S. label instructions), I can help translate the mg/kg/day target into an example daily dosing plan to discuss with your prescriber.
If you want, paste the dosing section from your Absorica LD medication guide or tell me your weight and prescribed daily strength, and I’ll interpret it clearly.